IGC - Why IGC Pharma Stock Is Moving Higher | Benzinga
IGC Pharma, Inc. (NASDAQ:IGC) shares are trading higher Tuesday after the company provided preclinical trial data on its drug candidate TGR-63 showing the drug reduces plaque in Alzheimer’s.
The Details:
IGC Pharma highlighted data from a trial in which the group treated with TGR-63 showed a 78% and 85% reduction in the cortical and hippocampal amyloid load, respectively, reaffirming its potential to thwart the progression of Alzheimer’s disease. IGC Pharma stated it hopes to progress TGR-63 ...